US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

251.15

-7.2000-2.79%

Post-market: 251.150.00000.00%17:28 EDT

Volume:656.36K

Turnover:166.30M

Market Cap:32.75B

PE:-119.69

High:260.00

Open:259.92

Low:250.35

Close:258.35

Loading ...

Overview Company News Filings

Alnylam Pharmaceuticals Inc Qtrly Adj EPS $0.06

THOMSON REUTERS

Alnylam Pharmaceuticals Inc: Reiterates Product Sales and Profitability Guidance for 2025

THOMSON REUTERS

Alnylam Pharmaceuticals Q4 2024 Adj. EPS $0.06, Sales $593.166M Beat $583.791M Estimate

BRIEF-Alnylam Pharmaceuticals Q4 Adjusted Net Income USD 8.048 Million Vs. IBES Estimate USD -76.1 Million

Alnylam Pharmaceuticals Q4 Operating Income USD -105.159 Million

THOMSON REUTERS

Alnylam Pharmaceuticals Price Target Maintained With a $300.00/Share by RBC Capital

ILMN vs. ALNY: Which Stock Is the Better Value Option?

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

IMVT Q3 Loss Wider Than Expected, Stock Down, Pipeline in Focus

DNLI Reports Upbeat Longer-Term Data From Hunter Syndrome Study

GHRS Stock Rallies 55% in a Week: Here's What You Should Know

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Are Medical Stocks Lagging Guardant Health (GH) This Year?

Alnylam treatment of ATTR amyloidosis granted orphan designation

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales

PFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS

BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALNY/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALNY\",,,,,undefined,":{"symbol":"ALNY","market":"US","secType":"STK","nameCN":"Alnylam Pharmaceuticals","latestPrice":251.15,"timestamp":1746820800000,"preClose":258.35,"halted":0,"volume":656363,"hourTrading":{"tag":"盘后","latestPrice":251.15,"preClose":251.15,"latestTime":"17:28 EDT","volume":2640,"amount":667823.982,"timestamp":1746826094037},"delay":0,"floatShares":125391844,"shares":130388393,"eps":-2.09826,"marketStatus":"Market Closed","change":-7.2,"latestTime":"05-09 16:00:00 EDT","open":259.92,"high":260,"low":250.35,"amount":166298991.42268,"amplitude":0.037352,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.09826,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1085630400000,"exchange":"NASDAQ","adjPreClose":258.35,"preHourTrading":{"tag":"盘前","latestPrice":259,"preClose":258.35,"latestTime":"09:29 EDT","volume":637,"amount":164574.2371,"timestamp":1746797399922},"postHourTrading":{"tag":"盘后","latestPrice":251.15,"preClose":251.15,"latestTime":"17:28 EDT","volume":2640,"amount":667823.982,"timestamp":1746826094037},"volumeRatio":0.5474240760464901,"impliedVol":0.4834,"impliedVolPercentile":0.704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALNY\",,,,,undefined,":{"symbol":"ALNY","floatShares":125391844,"roa":"-1.79%","roe":"-1500.66%","lyrEps":-2.179042,"volumeRatio":0.5474240760464901,"shares":130388393,"dividePrice":0,"high":260,"amplitude":0.037352,"preClose":258.35,"low":250.35,"week52Low":144.73,"pbRate":"283.68","psRate":"13.95","week52High":304.39,"institutionHeld":0.9873,"latestPrice":251.15,"eps":-2.09826,"divideRate":0,"volume":656363,"delay":0,"ttmEps":-2.09826,"open":259.92,"prevYearClose":235.31,"prevWeekClose":259.39,"prevMonthClose":263.24,"prevQuarterClose":270.02,"fiveDayClose":259.39,"twentyDayClose":226.28,"sixtyDayClose":265.96},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALNY\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511542958","title":"Alnylam Pharmaceuticals Inc Qtrly Adj EPS $0.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2511542958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511542958?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:01","pubTimestamp":1739451710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P41C2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","ALNY","BK4139","BK4585","BK4548"],"gpt_icon":0},{"id":"2511542664","title":"Alnylam Pharmaceuticals Inc: Reiterates Product Sales and Profitability Guidance for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2511542664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511542664?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:01","pubTimestamp":1739451710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P41C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","ALNY","BK4139","BK4585","BK4548"],"gpt_icon":0},{"id":"2511542434","title":"Alnylam Pharmaceuticals Q4 2024 Adj. EPS $0.06, Sales $593.166M Beat $583.791M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2511542434","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511542434?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:01","pubTimestamp":1739451701,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals Q4 2024 Adj. EPS $0.06, Sales $593.166M Beat $583.791M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43690960/alnylam-pharmaceuticals-q4-2024-adj-eps-0-06-sales-593-166m-beat-583-791m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alnylam Pharmaceuticals Q4 2024 Adj. EPS $0.06, Sales $593.166M Beat $583.791M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY"],"gpt_icon":0},{"id":"2511542636","title":"BRIEF-Alnylam Pharmaceuticals Q4 Adjusted Net Income USD 8.048 Million Vs. IBES Estimate USD -76.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2511542636","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511542636?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:00","pubTimestamp":1739451647,"startTime":"0","endTime":"0","summary":"Feb 13  - Alnylam Pharmaceuticals Q4 operating income USD -105.159 million.Q4 adjusted operating income USD -13.514 million vs. IBES estimate USD -63.4 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nPLX8B28AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY","BK4588","BK4548","BK4139","BK4585"],"gpt_icon":0},{"id":"2511554252","title":"Alnylam Pharmaceuticals Q4 Operating Income USD -105.159 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2511554252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511554252?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:00","pubTimestamp":1739451602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nPLX8B28AF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALNY","BK4548","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2510332431","title":"Alnylam Pharmaceuticals Price Target Maintained With a $300.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2510332431","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510332431?lang=en_us&edition=fundamental","pubTime":"2025-02-12 01:11","pubTimestamp":1739293860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 12:11 ET (17:11 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY"],"gpt_icon":0},{"id":"2510435876","title":"ILMN vs. ALNY: Which Stock Is the Better Value Option?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510435876","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510435876?lang=en_us&edition=fundamental","pubTime":"2025-02-12 00:40","pubTimestamp":1739292007,"startTime":"0","endTime":"0","summary":"Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Illumina  and Alnylam Pharmaceuticals . But which of these two stocks offers value investors a better bang for their buck right now?There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.Illumina and Alnylam Pharmaceuticals are both sporting a Zacks Rank of # 2  right now. Investors should feel comfortable knowing that both of these stocks have an improving earnings outlook since the Zacks Rank favors companies that have witnessed positive analyst estimate revisions. But this is just one factor that value investors are interested in.Alnylam Pharmaceuticals, Inc.  : Free Stock Analysis Report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ilmn-vs-alny-stock-better-164007112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","BK4121","BK4535","ILMN","BK4588","BK4585","BK4534","BK4139","BK4548"],"gpt_icon":0},{"id":"2510838260","title":"Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva","url":"https://stock-news.laohu8.com/highlight/detail?id=2510838260","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510838260?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:40","pubTimestamp":1739277600,"startTime":"0","endTime":"0","summary":"Shares of Axsome Therapeutics AXSM jumped 20.2% on Monday after the company announced that it has entered into a settlement agreement with Teva Pharmaceuticals TEVA related to patents for the psychiatry drug, Auvelity.The settlement agreement resolves the patent litigation brought by Axsome on Teva for submitting an abbreviated new drug application to the FDA, seeking marketing approval for a generic version ofAuvelity in the United States before applicable patents expire.Auvelity is approved for the treatment of adults with major depressive disorder . It is the first approved drug in Axsome’s portfolio. Auvelity was launched in the United States in 2022.The company is conducting several label expansion studies on Auvelity targeting other central nervous system disorders like Alzheimer’s disease  associated with agitation and smoking cessation.In the past three months, shares of Axsome have surged 27.7% against the industry’s 7.8% decline.Axsome is also currently gearing up to submit a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-stock-surges-20-auvelity-124000478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4584","BK4585","BK4548","BK4559","IE00B7SZLL34.SGD","BK4007","BK4557","BK4596","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B19Z3581.USD","BK4588","ALNY","BK4139","TEVA","AXSM","BMRN","BK4505","BK4566"],"gpt_icon":0},{"id":"2510887892","title":"Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510887892","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510887892?lang=en_us&edition=fundamental","pubTime":"2025-02-11 02:42","pubTimestamp":1739212920,"startTime":"0","endTime":"0","summary":"The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected fourth-quarter results but provided a lackluster guidance for 2025. Regeneron also beat on fourth-quarter earnings and sales and initiated a quarterly dividend. Amgen’s fourth-quarter results were decent as it beat on earnings as well as sales. However, investors were disappointed by a regulatory setback for its obesity drug.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Per the Zacks classification, the pharma/biotech industry falls under the broader Medical sector, comprising pharma/biotech and generic companies, and medical device companies.Quite a few biotech giants like Vertex Pharmaceuticals VRTX, Gilead Sciences GILD, Biogen BIIB, Alnylam Pharmaceuticals ALNY and Moderna MRNA are scheduled to report results this week. Let’s see how things might have shaped up for these c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-biotech-bigwig-stocks-surpass-184200903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIIB","VRTX","ALNY","MRNA"],"gpt_icon":0},{"id":"2510086282","title":"Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2510086282","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510086282?lang=en_us&edition=fundamental","pubTime":"2025-02-10 22:16","pubTimestamp":1739196962,"startTime":"0","endTime":"0","summary":"The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.The average prediction of analysts places 'Revenues- Product revenues, net' at $437.81 million. The estimate suggests a cha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ahead-alnylam-alny-q4-earnings-141602970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY"],"gpt_icon":0},{"id":"2509725357","title":"IMVT Q3 Loss Wider Than Expected, Stock Down, Pipeline in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2509725357","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509725357?lang=en_us&edition=fundamental","pubTime":"2025-02-07 23:09","pubTimestamp":1738940940,"startTime":"0","endTime":"0","summary":"Immunovant, Inc.IMVT reported third-quarter fiscal 2025 net loss of 76 cents per share, wider than the Zacks Consensus Estimate of a loss of 73 cents. The reported figure is also wider than the year-ago quarter's loss of 36 cents per share.See the ZacksEarnings Calendar to stay ahead of market-making news.Currently, Immunovant does not have any approved product in its portfolio. As a result, it is yet to generate revenues.The stock declined 9.6% following the lower-than-expected earnings results.Research and development (R&D) expenses totaled $94.5 million, up 96% from the year-ago quarter’s figure. The massive uptick can be attributed to activities in preparation for potential future clinical studies of IMVT-1402, including contract manufacturing costs for drug substance, higher overall clinical study costs related to batoclimab development programs and increased personnel-related expenses.The broad set of late-stage studies expected to be initiated for IMVT-1402 will include several ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imvt-q3-loss-wider-expected-150900575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","BK4566","GD","IE00B19Z4B17.USD","ALNY","BK4516","IE00B7SZLL34.SGD","MG","BK4196","BK4588","BK4187","BK4585","LU0170899867.USD","CSTL","IE0002270589.USD","IMVT","IE0031619046.USD","IE00B19Z3B42.SGD","IE00B7SZL793.SGD","BK4123","BK4139","BMRN","IE00B19Z3581.USD","IE00B66KJ199.SGD","BK4548"],"gpt_icon":0},{"id":"2509801725","title":"DNLI Reports Upbeat Longer-Term Data From Hunter Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2509801725","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509801725?lang=en_us&edition=fundamental","pubTime":"2025-02-07 22:54","pubTimestamp":1738940040,"startTime":"0","endTime":"0","summary":"Denali TherapeuticsDNLI reported primary analysis data from an early to mid-stage study of its pipeline candidate, tividenofusp alfa , in 47 patients with Hunter syndrome  over a 24-week treatment period, along with additional long-term follow-up data. DNLI’s wholly-owned program, tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase replacement therapy in development for MPS II.Per the additional long-term data readout from the phase I/II study, treatment with tividenofusp alfa resulted in significant and substantial reductions in key disease biomarkers within the central nervous system and peripheral system, bringing them to normal or near-normal levels. Such biomarkers included cerebrospinal fluid and urine heparan sulfate, as well as neurofilament light, a recognized marker of neurodegeneration.Per Denali, such efficacy data suggests the pervasive nature of treatment effects in MPS II patients over the longer term.Shares of DNLI have plunged 28.1% in the p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dnli-reports-upbeat-longer-term-145400778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","CSTL","BK4585","DNLI","BK4196","BMRN","IE00B19Z3581.USD","BK4548","BK4588","BK4139","BK4566","BK4535","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"2509209176","title":"GHRS Stock Rallies 55% in a Week: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209176","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509209176?lang=en_us&edition=fundamental","pubTime":"2025-02-06 23:25","pubTimestamp":1738855500,"startTime":"0","endTime":"0","summary":"Shares of GH Research PLC GHRS have rallied 54.8% in a week after the company, on Feb. 3, 2025, announced that it has met the primary goal in a mid-stage study of its investigational, inhalable mebufotenin product candidate, GH001, to treat patients with treatment-resistant depression .Per the data readout from the phase IIb TRD study, 40 patients treated with GH001 achieved a significant 15.2-point reduction in Montgomery-sberg Depression Rating Scale  score by Day 8, while the placebo group, comprising 41 patients, showed a slight increase of 0.3 points. Please note that MADRS is a metric showing the improvement of depressive symptoms in patients compared with placebo after the treatment period.It was observed that most patients receiving GH001 achieved remission with a 57.5% remission rate on Day 8 compared with 0% in the placebo group. Furthermore, in the open-label extension  portion of the phase IIb study, TRD patients who had remission on Day 8 after their first dosage had a 91.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ghrs-stock-rallies-55-week-152500374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","CSTL","GHRS","IE0002270589.USD","BK4588","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","ALNY","BK4007","BK4196","BK4548","BK4539","BK4585","BK4566"],"gpt_icon":0},{"id":"2509920916","title":"Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2509920916","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509920916?lang=en_us&edition=fundamental","pubTime":"2025-02-06 23:01","pubTimestamp":1738854066,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on higher revenues when Alnylam Pharmaceuticals  reports results for the quarter ended December 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 13, 2025, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This RNA interference drug developer is expected to post quarterly loss of $0.21 per share in its upcoming report, which represents a year-over-year change of +80.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alnylam-pharmaceuticals-alny-may-report-150106520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","EXEL"],"gpt_icon":0},{"id":"2509203268","title":"Are Medical Stocks Lagging  Guardant Health (GH) This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2509203268","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509203268?lang=en_us&edition=fundamental","pubTime":"2025-02-06 22:40","pubTimestamp":1738852811,"startTime":"0","endTime":"0","summary":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Guardant Health  is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?Let's take a closer look at the stock's year-to-date performance to find out.Guardant Health is one of 1013 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Guardant Health is currently sporting a Zacks Rank of #2 .Another stock in the Medical ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-stocks-lagging-guardant-health-144011595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GH","BK4535","BK4196","BK4588","ALNY","BK4551","BK4548","BK4585","BK4139"],"gpt_icon":0},{"id":"2509495060","title":"Alnylam treatment of ATTR amyloidosis granted orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2509495060","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509495060?lang=en_us&edition=fundamental","pubTime":"2025-02-05 04:05","pubTimestamp":1738699533,"startTime":"0","endTime":"0","summary":"Alnylam’s (ALNY) treatment of transthyretin-mediated amyloidosis, or ATTR amyloidosis, was granted FDA orphan designation, according to a post to t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-treatment-of-attr-amyloidosis-granted-orphan-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-treatment-of-attr-amyloidosis-granted-orphan-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4548","BK4585","BK4139","ALNY"],"gpt_icon":0},{"id":"2509460299","title":"Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2509460299","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509460299?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:36","pubTimestamp":1738686960,"startTime":"0","endTime":"0","summary":"Pfizer PFE reported fourth-quarter 2024 adjusted earnings per share of 63 cents, which beat the Zacks Consensus Estimate of 48 cents per share. The company had recorded earnings of 10 cents per share in the year-ago quarter.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Revenues came in at $17.76 billion, up 22% from the year-ago quarter on a reported basis. Revenues reflected an operational increase of 21% and a positive currency impact of 1%. Total revenues also beat the Zacks Consensus Estimate of $17.5 billion.Higher sales of Pfizer’s key non-COVID products like Vyndaqel and Eliquis and newly acquired products from Seagen, coupled with higher Paxlovid sales, drove the top line in the quarter. However, sales of some key drugs like Prevnar, Xeljanz and Ibrance and new RSV vaccine, Abrysvo declined in the quarter.Pfizer's COVID revenues include direct sales and alliance revenues from its partner, BioNTech BNTX, for Comirnaty and product revenues from its oral a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizers-q4-earnings-beat-estimates-163600258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","PFE"],"gpt_icon":1},{"id":"2509466090","title":"PFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466090","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509466090?lang=en_us&edition=fundamental","pubTime":"2025-02-04 22:26","pubTimestamp":1738679160,"startTime":"0","endTime":"0","summary":"PfizerPFE announced positive top-line results from the progression-free survival  analysis of a late-stage study of its oncology drug, Braftovi , for treating patients with metastatic colorectal cancer  harboring a BRAF V600E mutation. Braftovi is an oral small-molecule kinase inhibitor that targetsBRAF V600E.The phase III BREAKWATER study is evaluating the candidate's safety and efficacy in combination with Eli Lilly’s LLY Erbitux  and chemotherapy  in mCRC patients harboring a BRAF V600E mutation.BRAF mutations are found in 8-12% of mCRC cases and are linked to a poorer prognosis. The BRAF V600E mutation is the most common and more than doubles the risk of death compared to patients without any mutation. Despite the high unmet need, no biomarker-driven therapies were approved for previously untreated BRAF V600E-mutant mCRC until December 2024. Thus, Pfizer has the first-mover advantage in t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfes-colorectal-cancer-drug-meets-142600063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1064131342.USD","LU2361045086.USD","LU0354030438.USD","IE00BK4W5M84.HKD","LU0471298694.HKD","LU1868836757.USD","LU1023059063.AUD","LU1066053197.SGD","LU0823416689.USD","BK4534","LU1127390331.HKD","LU2237443895.HKD","BK4581","LU2361044949.HKD","LU1894683264.USD","LU1291159041.SGD","SG9999002232.USD","LU1623119135.USD","ALNY","LU2361044865.SGD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU2106854487.HKD","LU1093756325.SGD","BK4588","LU1720051017.SGD","BK4007","LU0097036916.USD","IE00BBT3K403.USD","ORR","SGXZ99366536.SGD","LU2237438978.USD","PFE","LU0238689110.USD","PFS","LLY","LU1280957306.USD","LU2491050154.USD","LU1066051498.USD","LU0306806265.USD","LU0868494617.USD","LU0882574055.USD","LU2491049909.HKD","LU0170899867.USD","CSTL","BK4516","LU0640476718.USD","LU2324357040.USD","IE0002141913.USD","LU0079474960.USD"],"gpt_icon":1},{"id":"2508120507","title":"BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi","url":"https://stock-news.laohu8.com/highlight/detail?id=2508120507","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508120507?lang=en_us&edition=fundamental","pubTime":"2025-02-04 02:34","pubTimestamp":1738607640,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb BMY announced that it has obtained a positive opinion from the Committee for Medicinal Products for Human Use  of the European Medicines Agency for two of its drugs.The CHMP recommended approval of Opdivo  plus Yervoy  for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma .The CHMP also recommended approval of Breyanzi  for relapsed or refractory follicular lymphoma.Shares of BMY have risen 29.8% in the past year against the industry’s decline of 8.7%.The positive CHMP opinion was based on late-stage CheckMate -9DW trial, which demonstrated statistically significant and clinically meaningful improvement in overall survival with Opdivo plus Yervoy compared to investigator’s choice of lenvatinib or sorafenib in RCC patients.We note that Breyanzi is currently approved in the EU for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma , high-grade B-cell lymphoma , primary mediastinal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmy-gets-positive-chmp-opinion-183400618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","IE00BJJMRZ35.SGD","LU0225284248.USD","LU1291159041.SGD","LU0456855351.SGD","CHMP","LU0306806265.USD","LU2125154935.USD","LU2242652126.USD","LU2133065610.SGD","LU1323610961.USD","LU1868836914.USD","ALNY","LU1670710661.SGD","BMY","IE00B2B36J28.USD","LU1989771016.USD","HCC","IE00B7SZLL34.SGD","BK4532","LU1670710588.SGD","LU2360032135.SGD","BK4588","LU1093756168.USD","BK4022","IE00BFTCPJ56.SGD","LU0096364046.USD","LU0321505439.SGD","BK4006","LU0882574055.USD","LU1261432733.SGD","IE0002141913.USD","IE0002270589.USD","LU1585245621.USD","IE0009355771.USD","LU1074936037.SGD","LU1868837300.USD","LU2242646821.SGD","CAR","LU1670711040.USD","LU0225771236.USD","BMRN","IE00B19Z3581.USD","LU1868837136.USD","LU1718418525.SGD","BK4007","EXEL","BK4548","LU0985481810.HKD","LU0321505868.SGD"],"gpt_icon":0},{"id":"2508512562","title":"Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2508512562","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508512562?lang=en_us&edition=fundamental","pubTime":"2025-02-03 23:53","pubTimestamp":1738597980,"startTime":"0","endTime":"0","summary":"Pfizer’s PFE non-COVID operational revenues improved in the first three quarters of 2024, driven by its key in-line products like Vyndaqel and Eliquis, new launches like Abrysvo and newly acquired products like Nurtec as well as those acquired from Seagen . The trend is expected to have continued in the fourth quarter.In the past year, Pfizer’s stock has declined 0.2% compared with a decrease of 2.5% for the industry.Vyndaqel/Vyndamax sales are likely to have benefited from continued demand growth, primarily in the United States and developed Europe.Among other acquired products, Nurtec sales are likely to have improved sequentially, driven by strong demand in the United States and launches in international markets. However, regarding another newly acquired drug, Oxbryta, in September, Pfizer announced that it is voluntarily withdrawing all lots of the sickle cell disease drug from all global markets where it is approved. Sales of Oxbryta are likely to have be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/non-covid-drugs-drive-pfes-155300754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","ALNY","PFE"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALNY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-01","symbol":"ALNY","fiscalQuarterEnding":"2025/03","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-02-13","symbol":"ALNY","fiscalQuarterEnding":"2024/12","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-01-12","symbol":"ALNY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-10-31","symbol":"ALNY","fiscalQuarterEnding":"2024/09","expectedEps":-1.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":-0.87},{"market":"US","date":"2024-08-01","symbol":"ALNY","fiscalQuarterEnding":"2024/06","expectedEps":-1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALNY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.5758,"hold":0.2121,"sell":0,"strongSell":0.0303,"meanLabel":"BUY","meanPercent":0.5758,"analysts":33,"updateTime":1743480000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALNY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALNY","date":"2025-05-09","current":-124.900691,"percent":0.061125,"low":-528.985936,"twenty":-47.223923,"median":-23.401211,"eighty":-19.500963,"high":-16.042363,"avg":-58.393952,"sd":103.052034,"marketCap":33685841331},"quantilePoints":[{"date":"2020-05-15","current":-18.041081,"twenty":-28.208919,"median":-18.407515,"eighty":-12.765797,"marketCap":15992011351},{"date":"2020-05-22","current":-18.2017,"twenty":-28.039591,"median":-18.384726,"eighty":-12.765797,"marketCap":16134387098},{"date":"2020-05-29","current":-17.521662,"twenty":-27.765103,"median":-18.335477,"eighty":-12.765797,"marketCap":15531586555},{"date":"2020-06-05","current":-16.604274,"twenty":-27.102412,"median":-18.20543,"eighty":-12.765797,"marketCap":14718393378},{"date":"2020-06-12","current":-16.317971,"twenty":-26.753002,"median":-18.116275,"eighty":-12.765797,"marketCap":14464608085},{"date":"2020-06-19","current":-19.613058,"twenty":-26.23451,"median":-18.069148,"eighty":-12.765797,"marketCap":17385446085},{"date":"2020-06-26","current":-19.767922,"twenty":-25.746405,"median":-18.069148,"eighty":-12.765797,"marketCap":17522720856},{"date":"2020-07-02","current":-19.503742,"twenty":-25.587866,"median":-18.069148,"eighty":-12.765797,"marketCap":17288546246},{"date":"2020-07-10","current":-21.114847,"twenty":-25.220551,"median":-18.069148,"eighty":-12.765797,"marketCap":18716665299},{"date":"2020-07-17","current":-20.608612,"twenty":-25.044714,"median":-18.069148,"eighty":-12.765797,"marketCap":18267926760},{"date":"2020-07-24","current":-19.924087,"twenty":-24.907136,"median":-18.069148,"eighty":-12.765797,"marketCap":17661149198},{"date":"2020-07-31","current":-18.968876,"twenty":-24.745683,"median":-18.069148,"eighty":-12.765797,"marketCap":16814429177},{"date":"2020-08-07","current":-19.671157,"twenty":-24.475863,"median":-18.069148,"eighty":-12.765797,"marketCap":16645142953},{"date":"2020-08-14","current":-18.658338,"twenty":-24.349293,"median":-18.069148,"eighty":-12.765797,"marketCap":15788126257},{"date":"2020-08-21","current":-18.721383,"twenty":-24.209555,"median":-18.069148,"eighty":-12.765797,"marketCap":15841472357},{"date":"2020-08-28","current":-18.01008,"twenty":-24.184809,"median":-18.052264,"eighty":-12.765797,"marketCap":15239589184},{"date":"2020-09-04","current":-16.834169,"twenty":-24.081905,"median":-18.021266,"eighty":-12.765797,"marketCap":14244568445},{"date":"2020-09-11","current":-16.780718,"twenty":-23.925961,"median":-17.98312,"eighty":-12.765797,"marketCap":14199340230},{"date":"2020-09-18","current":-18.126574,"twenty":-23.703719,"median":-17.948655,"eighty":-12.765797,"marketCap":15338163499},{"date":"2020-09-25","current":-18.955743,"twenty":-23.651695,"median":-17.943173,"eighty":-12.765797,"marketCap":16039780686},{"date":"2020-10-02","current":-18.595294,"twenty":-23.651695,"median":-17.943173,"eighty":-12.765797,"marketCap":15734780157},{"date":"2020-10-09","current":-20.146729,"twenty":-23.651695,"median":-17.943173,"eighty":-12.765797,"marketCap":17047558101},{"date":"2020-10-16","current":-19.927445,"twenty":-23.651695,"median":-17.943173,"eighty":-12.765797,"marketCap":16862006448},{"date":"2020-10-23","current":-18.069012,"twenty":-23.651695,"median":-17.955258,"eighty":-12.765797,"marketCap":15289456190},{"date":"2020-10-30","current":-16.853356,"twenty":-23.651695,"median":-17.902926,"eighty":-12.765797,"marketCap":14260804215},{"date":"2020-11-06","current":-17.047782,"twenty":-23.651695,"median":-17.882699,"eighty":-12.765797,"marketCap":15188311800},{"date":"2020-11-13","current":-17.671115,"twenty":-23.424433,"median":-17.782029,"eighty":-12.765797,"marketCap":15743655871},{"date":"2020-11-20","current":-16.261442,"twenty":-22.970365,"median":-17.728873,"eighty":-12.765797,"marketCap":14487741769},{"date":"2020-11-27","current":-16.93433,"twenty":-22.596923,"median":-17.671517,"eighty":-12.765797,"marketCap":15087234532},{"date":"2020-12-04","current":-16.895208,"twenty":-22.303795,"median":-17.633807,"eighty":-12.765797,"marketCap":15052380302},{"date":"2020-12-11","current":-16.906945,"twenty":-22.125764,"median":-17.533639,"eighty":-12.765797,"marketCap":15062836571},{"date":"2020-12-18","current":-18.568298,"twenty":-22.125764,"median":-17.509457,"eighty":-12.765797,"marketCap":16542979555},{"date":"2020-12-24","current":-17.938444,"twenty":-22.125764,"median":-17.509457,"eighty":-12.765797,"marketCap":15981826446},{"date":"2020-12-31","current":-16.948674,"twenty":-22.125764,"median":-17.407805,"eighty":-12.765797,"marketCap":15100014416},{"date":"2021-01-08","current":-19.125125,"twenty":-22.125764,"median":-17.366349,"eighty":-12.765797,"marketCap":17039071434},{"date":"2021-01-15","current":-21.694094,"twenty":-22.16479,"median":-17.374532,"eighty":-12.765797,"marketCap":19327832564},{"date":"2021-01-22","current":-22.479129,"twenty":-22.200105,"median":-17.490272,"eighty":-12.765797,"marketCap":20027240787},{"date":"2021-01-29","current":-19.623271,"twenty":-22.291086,"median":-17.589206,"eighty":-12.765797,"marketCap":17482881968},{"date":"2021-02-05","current":-21.531089,"twenty":-22.291086,"median":-17.651087,"eighty":-12.765797,"marketCap":19182606604},{"date":"2021-02-12","current":-21.527867,"twenty":-22.302203,"median":-17.687907,"eighty":-12.765797,"marketCap":18476958840},{"date":"2021-02-19","current":-21.137988,"twenty":-22.302203,"median":-17.739545,"eighty":-12.765797,"marketCap":18142333066},{"date":"2021-02-26","current":-20.189191,"twenty":-22.302203,"median":-17.787244,"eighty":-12.765797,"marketCap":17327999013},{"date":"2021-03-05","current":-19.547117,"twenty":-22.309147,"median":-17.893524,"eighty":-12.765238,"marketCap":16776919504},{"date":"2021-03-12","current":-19.384895,"twenty":-22.309147,"median":-17.942924,"eighty":-12.765238,"marketCap":16637687101},{"date":"2021-03-19","current":-19.652085,"twenty":-22.309147,"median":-17.981497,"eighty":-12.765238,"marketCap":16867011059},{"date":"2021-03-26","current":-18.573783,"twenty":-22.302203,"median":-18.021694,"eighty":-12.765797,"marketCap":15941525088},{"date":"2021-04-01","current":-19.33173,"twenty":-22.302203,"median":-18.044465,"eighty":-12.765797,"marketCap":16592056314},{"date":"2021-04-09","current":-18.894932,"twenty":-22.309147,"median":-18.076673,"eighty":-12.765238,"marketCap":16217161155},{"date":"2021-04-16","current":-18.983782,"twenty":-22.309147,"median":-18.133467,"eighty":-12.765238,"marketCap":16293419237},{"date":"2021-04-23","current":-18.688527,"twenty":-22.309147,"median":-18.196771,"eighty":-12.765238,"marketCap":16040007763},{"date":"2021-04-30","current":-18.864056,"twenty":-22.309147,"median":-18.239796,"eighty":-12.765238,"marketCap":16531534425},{"date":"2021-05-07","current":-17.611281,"twenty":-22.173873,"median":-18.209161,"eighty":-12.765238,"marketCap":15433663752},{"date":"2021-05-14","current":-18.201453,"twenty":-22.082787,"median":-18.178654,"eighty":-12.765238,"marketCap":15950861928},{"date":"2021-05-21","current":-18.786261,"twenty":-21.870084,"median":-18.165117,"eighty":-12.765238,"marketCap":16463358302},{"date":"2021-05-28","current":-19.045132,"twenty":-21.792177,"median":-18.165117,"eighty":-12.765238,"marketCap":16690220229},{"date":"2021-06-04","current":-19.529341,"twenty":-21.714437,"median":-18.165117,"eighty":-12.765238,"marketCap":17114557824},{"date":"2021-06-11","current":-22.134148,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":19397282500},{"date":"2021-06-18","current":-23.726272,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":20792542125},{"date":"2021-06-25","current":-23.525077,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":20616224565},{"date":"2021-07-02","current":-22.993922,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":20150746207},{"date":"2021-07-09","current":-23.706152,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":20774910369},{"date":"2021-07-16","current":-23.813456,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":20868946401},{"date":"2021-07-23","current":-24.46667,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":21441390746},{"date":"2021-07-30","current":-24.001239,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":21033509457},{"date":"2021-08-06","current":-26.167962,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":23202635104},{"date":"2021-08-13","current":-26.34355,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":23358325582},{"date":"2021-08-20","current":-26.509756,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":23505696721},{"date":"2021-08-27","current":-27.334081,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":24236610033},{"date":"2021-09-03","current":-26.466864,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":23467665459},{"date":"2021-09-10","current":-25.406635,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":22527580208},{"date":"2021-09-17","current":-25.512524,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":22621469885},{"date":"2021-09-24","current":-25.118456,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":22272057668},{"date":"2021-10-01","current":-25.826169,"twenty":-21.658936,"median":-18.165117,"eighty":-12.765238,"marketCap":22899573487},{"date":"2021-10-08","current":-27.303252,"twenty":-21.692321,"median":-18.178654,"eighty":-12.765238,"marketCap":24209275064},{"date":"2021-10-15","current":-27.95467,"twenty":-21.792177,"median":-18.209161,"eighty":-12.765238,"marketCap":24786874852},{"date":"2021-10-22","current":-26.621006,"twenty":-21.870084,"median":-18.258632,"eighty":-12.765238,"marketCap":23604340306},{"date":"2021-10-29","current":-22.775358,"twenty":-22.053632,"median":-18.328908,"eighty":-12.765238,"marketCap":19083563802},{"date":"2021-11-05","current":-26.727788,"twenty":-22.165324,"median":-18.375271,"eighty":-12.792321,"marketCap":22395320393},{"date":"2021-11-12","current":-24.389731,"twenty":-22.290994,"median":-18.415132,"eighty":-12.792321,"marketCap":20436253113},{"date":"2021-11-19","current":-25.835672,"twenty":-22.341244,"median":-18.436098,"eighty":-12.792321,"marketCap":21647813037},{"date":"2021-11-26","current":-26.910493,"twenty":-22.505407,"median":-18.449104,"eighty":-12.792321,"marketCap":22548409899},{"date":"2021-12-03","current":-24.459673,"twenty":-22.750073,"median":-18.543467,"eighty":-12.792321,"marketCap":20494857690},{"date":"2021-12-10","current":-24.786544,"twenty":-22.910315,"median":-18.581226,"eighty":-12.792321,"marketCap":20768744386},{"date":"2021-12-17","current":-27.772634,"twenty":-23.117321,"median":-18.612424,"eighty":-12.792321,"marketCap":23270801008},{"date":"2021-12-23","current":-27.741231,"twenty":-23.229497,"median":-18.621548,"eighty":-12.792321,"marketCap":23244488749},{"date":"2021-12-31","current":-24.205598,"twenty":-23.459621,"median":-18.66031,"eighty":-12.792321,"marketCap":20281967595},{"date":"2022-01-07","current":-21.143857,"twenty":-23.528897,"median":-18.694902,"eighty":-12.800976,"marketCap":17716522349},{"date":"2022-01-14","current":-21.19667,"twenty":-23.528897,"median":-18.73009,"eighty":-12.800976,"marketCap":17760774784},{"date":"2022-01-21","current":-19.470962,"twenty":-23.528897,"median":-18.766942,"eighty":-12.800976,"marketCap":16314796554},{"date":"2022-01-28","current":-18.854331,"twenty":-23.528897,"median":-18.78123,"eighty":-12.800976,"marketCap":15798119469},{"date":"2022-02-04","current":-20.757036,"twenty":-23.528897,"median":-18.795437,"eighty":-12.800976,"marketCap":17392403159},{"date":"2022-02-11","current":-21.250498,"twenty":-23.528897,"median":-18.814861,"eighty":-12.800976,"marketCap":18122934678},{"date":"2022-02-18","current":-20.790982,"twenty":-23.528897,"median":-18.854,"eighty":-12.800976,"marketCap":17731048455},{"date":"2022-02-25","current":-21.848151,"twenty":-23.528897,"median":-18.879629,"eighty":-12.800976,"marketCap":18632627190},{"date":"2022-03-04","current":-23.178773,"twenty":-23.528897,"median":-18.879629,"eighty":-12.800976,"marketCap":19767414291},{"date":"2022-03-11","current":-21.842512,"twenty":-23.528897,"median":-18.879629,"eighty":-12.800976,"marketCap":18627818770},{"date":"2022-03-18","current":-23.292948,"twenty":-23.528897,"median":-18.879629,"eighty":-12.800976,"marketCap":19864784794},{"date":"2022-03-25","current":-23.089971,"twenty":-23.528897,"median":-18.879629,"eighty":-12.800976,"marketCap":19691681677},{"date":"2022-04-01","current":-23.862409,"twenty":-23.546794,"median":-18.879629,"eighty":-12.800976,"marketCap":20350435206},{"date":"2022-04-08","current":-23.132336,"twenty":-23.546794,"median":-18.895899,"eighty":-12.800976,"marketCap":19727811060},{"date":"2022-04-14","current":-23.687217,"twenty":-23.592833,"median":-18.895899,"eighty":-12.800976,"marketCap":20201027431},{"date":"2022-04-22","current":-23.63909,"twenty":-23.68627,"median":-18.895899,"eighty":-12.800976,"marketCap":20159983154},{"date":"2022-04-29","current":-18.054231,"twenty":-23.68627,"median":-18.892548,"eighty":-12.800976,"marketCap":16120153177},{"date":"2022-05-06","current":-18.232838,"twenty":-23.68627,"median":-18.867179,"eighty":-12.800976,"marketCap":16279627075},{"date":"2022-05-13","current":-17.112483,"twenty":-23.68627,"median":-18.867179,"eighty":-12.800976,"marketCap":15279290806},{"date":"2022-05-20","current":-17.897273,"twenty":-23.68627,"median":-18.867179,"eighty":-12.800976,"marketCap":15980009448},{"date":"2022-05-27","current":-17.288384,"twenty":-23.68627,"median":-18.867179,"eighty":-12.800976,"marketCap":15436348433},{"date":"2022-06-03","current":-17.795791,"twenty":-23.68627,"median":-18.86466,"eighty":-12.800976,"marketCap":15889399279},{"date":"2022-06-10","current":-17.875623,"twenty":-23.68627,"median":-18.833595,"eighty":-12.800976,"marketCap":15960679279},{"date":"2022-06-17","current":-18.54946,"twenty":-23.68627,"median":-18.809998,"eighty":-12.800976,"marketCap":16562330803},{"date":"2022-06-24","current":-19.958023,"twenty":-23.686507,"median":-18.809063,"eighty":-12.792321,"marketCap":17819999952},{"date":"2022-07-01","current":-20.059505,"twenty":-23.686507,"median":-18.809063,"eighty":-12.792321,"marketCap":17910610121},{"date":"2022-07-08","current":-20.633213,"twenty":-23.686507,"median":-18.809063,"eighty":-12.792321,"marketCap":18422859611},{"date":"2022-07-15","current":-19.672522,"twenty":-23.686507,"median":-18.806355,"eighty":-12.792321,"marketCap":17565083343},{"date":"2022-07-22","current":-19.377549,"twenty":-23.686507,"median":-18.806355,"eighty":-12.792321,"marketCap":17301709784},{"date":"2022-07-29","current":-17.383784,"twenty":-23.686507,"median":-18.791626,"eighty":-12.792321,"marketCap":17048572440},{"date":"2022-08-05","current":-26.75125,"twenty":-23.729842,"median":-18.78673,"eighty":-12.792321,"marketCap":26235405266},{"date":"2022-08-12","current":-28.620092,"twenty":-23.796258,"median":-18.78673,"eighty":-12.792321,"marketCap":28068210822},{"date":"2022-08-19","current":-26.431821,"twenty":-23.876597,"median":-18.78673,"eighty":-12.792321,"marketCap":25922135947},{"date":"2022-08-26","current":-25.816216,"twenty":-24.032739,"median":-18.78673,"eighty":-12.792321,"marketCap":25318402355},{"date":"2022-09-02","current":-25.144314,"twenty":-24.212805,"median":-18.78673,"eighty":-12.792321,"marketCap":24659456546},{"date":"2022-09-09","current":-27.325242,"twenty":-24.354167,"median":-18.791626,"eighty":-12.792321,"marketCap":26798329827},{"date":"2022-09-16","current":-26.068333,"twenty":-24.408238,"median":-18.791626,"eighty":-12.792321,"marketCap":25565657067},{"date":"2022-09-23","current":-24.572769,"twenty":-24.42372,"median":-18.791626,"eighty":-12.792321,"marketCap":24098932516},{"date":"2022-09-30","current":-24.49689,"twenty":-24.416664,"median":-18.791626,"eighty":-12.792321,"marketCap":24024516049},{"date":"2022-10-07","current":-23.964508,"twenty":-24.395979,"median":-18.791626,"eighty":-12.792321,"marketCap":23502400517},{"date":"2022-10-14","current":-22.706375,"twenty":-24.320425,"median":-18.791626,"eighty":-12.792321,"marketCap":22268527491},{"date":"2022-10-21","current":-24.340235,"twenty":-24.205881,"median":-18.791626,"eighty":-12.792321,"marketCap":23870882053},{"date":"2022-10-28","current":-21.284168,"twenty":-24.156444,"median":-18.791626,"eighty":-12.792321,"marketCap":25160504135},{"date":"2022-11-04","current":-21.682771,"twenty":-23.968011,"median":-18.791626,"eighty":-12.792321,"marketCap":25631702271},{"date":"2022-11-11","current":-22.518485,"twenty":-23.880556,"median":-18.791626,"eighty":-12.792321,"marketCap":26619618990},{"date":"2022-11-18","current":-22.621518,"twenty":-23.817859,"median":-18.791626,"eighty":-12.792321,"marketCap":26741416942},{"date":"2022-11-25","current":-22.138615,"twenty":-23.747231,"median":-18.791626,"eighty":-12.792321,"marketCap":26170565936},{"date":"2022-12-02","current":-24.394939,"twenty":-23.7142,"median":-18.791626,"eighty":-12.792321,"marketCap":28837818049},{"date":"2022-12-09","current":-24.075432,"twenty":-23.686507,"median":-18.791626,"eighty":-12.792321,"marketCap":28460121371},{"date":"2022-12-16","current":-24.657205,"twenty":-23.686507,"median":-18.791626,"eighty":-12.792321,"marketCap":29147849199},{"date":"2022-12-23","current":-24.759198,"twenty":-23.686507,"median":-18.791626,"eighty":-12.792321,"marketCap":29268416868},{"date":"2022-12-30","current":-24.733179,"twenty":-23.686507,"median":-18.791626,"eighty":-12.792321,"marketCap":29237659810},{"date":"2023-01-06","current":-23.416643,"twenty":-23.630887,"median":-18.791626,"eighty":-12.792321,"marketCap":27681352650},{"date":"2023-01-13","current":-24.512542,"twenty":-23.568235,"median":-18.791626,"eighty":-12.792321,"marketCap":28976839954},{"date":"2023-01-20","current":-23.900587,"twenty":-23.568235,"median":-18.791626,"eighty":-12.792321,"marketCap":28253433938},{"date":"2023-01-27","current":-24.079595,"twenty":-23.568235,"median":-18.791626,"eighty":-12.792321,"marketCap":28465042500},{"date":"2023-02-03","current":-24.287742,"twenty":-23.54259,"median":-18.791626,"eighty":-12.792321,"marketCap":28711098968},{"date":"2023-02-10","current":-22.402963,"twenty":-23.491734,"median":-18.791626,"eighty":-12.792321,"marketCap":26483057650},{"date":"2023-02-17","current":-23.18664,"twenty":-23.419241,"median":-18.791626,"eighty":-12.792321,"marketCap":27409460252},{"date":"2023-02-24","current":-20.82611,"twenty":-23.352126,"median":-18.791626,"eighty":-12.792321,"marketCap":23557578902},{"date":"2023-03-03","current":-22.230758,"twenty":-23.22571,"median":-18.791626,"eighty":-12.792321,"marketCap":25146455549},{"date":"2023-03-10","current":-20.044774,"twenty":-23.141334,"median":-18.791626,"eighty":-12.792321,"marketCap":22673766268},{"date":"2023-03-17","current":-20.350943,"twenty":-23.097237,"median":-18.791626,"eighty":-12.792321,"marketCap":23020091724},{"date":"2023-03-24","current":-20.848057,"twenty":-23.009062,"median":-18.791626,"eighty":-12.792321,"marketCap":23582405100},{"date":"2023-03-31","current":-21.98275,"twenty":-22.988444,"median":-18.795437,"eighty":-12.800976,"marketCap":24865919516},{"date":"2023-04-06","current":-22.037619,"twenty":-22.988444,"median":-18.795437,"eighty":-12.800976,"marketCap":24927985010},{"date":"2023-04-14","current":-22.752015,"twenty":-22.994411,"median":-18.791626,"eighty":-12.792321,"marketCap":25736077742},{"date":"2023-04-21","current":-22.278082,"twenty":-22.994411,"median":-18.791626,"eighty":-12.792321,"marketCap":25199986512},{"date":"2023-04-28","current":-21.52911,"twenty":-22.994411,"median":-18.791626,"eighty":-12.792321,"marketCap":24352781997},{"date":"2023-05-05","current":-24.017238,"twenty":-22.999557,"median":-18.809063,"eighty":-12.792321,"marketCap":25576341122},{"date":"2023-05-12","current":-24.099092,"twenty":-23.091099,"median":-18.816972,"eighty":-12.792321,"marketCap":25663509138},{"date":"2023-05-19","current":-22.20241,"twenty":-23.108276,"median":-18.816972,"eighty":-12.792321,"marketCap":23643701684},{"date":"2023-05-26","current":-21.749872,"twenty":-23.108276,"median":-18.832054,"eighty":-12.792321,"marketCap":23161787082},{"date":"2023-05-30","current":-22.014145,"twenty":-23.108276,"median":-18.832054,"eighty":-12.792321,"marketCap":23443215247},{"date":"2023-06-08","current":-22.23749,"twenty":-23.114829,"median":-18.815818,"eighty":-12.766355,"marketCap":23681059405},{"date":"2023-06-16","current":-23.660587,"twenty":-23.137914,"median":-18.814665,"eighty":-12.765797,"marketCap":25196537624},{"date":"2023-06-23","current":-23.27821,"twenty":-23.163703,"median":-18.812635,"eighty":-12.765238,"marketCap":24789338464},{"date":"2023-06-30","current":-22.341562,"twenty":-23.168726,"median":-18.816972,"eighty":-12.76468,"marketCap":23791887311},{"date":"2023-07-07","current":-22.730955,"twenty":-23.168726,"median":-18.835136,"eighty":-12.76468,"marketCap":24206558015},{"date":"2023-07-14","current":-23.840667,"twenty":-23.244701,"median":-18.835136,"eighty":-12.76468,"marketCap":25388307259},{"date":"2023-07-21","current":-23.555346,"twenty":-23.292384,"median":-18.835136,"eighty":-12.76468,"marketCap":25084464461},{"date":"2023-07-28","current":-22.787084,"twenty":-23.294608,"median":-18.835136,"eighty":-12.76468,"marketCap":24266330369},{"date":"2023-08-04","current":-22.342995,"twenty":-23.300647,"median":-18.896865,"eighty":-12.76468,"marketCap":23762623945},{"date":"2023-08-11","current":-21.747103,"twenty":-23.300647,"median":-18.968876,"eighty":-12.76468,"marketCap":23128870639},{"date":"2023-08-18","current":-21.613116,"twenty":-23.300647,"median":-19.045132,"eighty":-12.76468,"marketCap":22986369896},{"date":"2023-08-25","current":-21.95161,"twenty":-23.300647,"median":-19.15429,"eighty":-12.76468,"marketCap":23346371774},{"date":"2023-09-01","current":-23.250348,"twenty":-23.300647,"median":-19.15429,"eighty":-12.76468,"marketCap":24727628978},{"date":"2023-09-08","current":-23.635856,"twenty":-23.392929,"median":-19.15429,"eighty":-12.76468,"marketCap":25137631117},{"date":"2023-09-15","current":-22.690892,"twenty":-23.42054,"median":-19.22846,"eighty":-12.76468,"marketCap":24132625875},{"date":"2023-09-22","current":-20.433086,"twenty":-23.42054,"median":-19.275075,"eighty":-12.76468,"marketCap":21731363350},{"date":"2023-09-29","current":-20.454242,"twenty":-23.42054,"median":-19.33425,"eighty":-12.76468,"marketCap":21753863467},{"date":"2023-10-06","current":-21.004296,"twenty":-23.42054,"median":-19.384895,"eighty":-12.76468,"marketCap":22338866518},{"date":"2023-10-13","current":-19.427005,"twenty":-23.421839,"median":-19.444236,"eighty":-12.764121,"marketCap":20661357769},{"date":"2023-10-20","current":-18.864022,"twenty":-23.421839,"median":-19.474784,"eighty":-12.764121,"marketCap":20062604646},{"date":"2023-10-27","current":-18.295163,"twenty":-23.429699,"median":-19.48809,"eighty":-12.759255,"marketCap":19457601490},{"date":"2023-11-03","current":-39.757333,"twenty":-23.462501,"median":-19.499111,"eighty":-12.759255,"marketCap":20270872498},{"date":"2023-11-10","current":-40.493261,"twenty":-23.518638,"median":-19.547117,"eighty":-12.810563,"marketCap":20646096350},{"date":"2023-11-17","current":-41.588538,"twenty":-23.5593,"median":-19.6194,"eighty":-12.915545,"marketCap":21204539875},{"date":"2023-11-24","current":-40.099453,"twenty":-23.594466,"median":-19.650722,"eighty":-12.992484,"marketCap":20445307666},{"date":"2023-12-01","current":-41.411325,"twenty":-23.641087,"median":-19.672522,"eighty":-13.142902,"marketCap":21114184967},{"date":"2023-12-08","current":-43.628953,"twenty":-23.68627,"median":-19.720205,"eighty":-13.297409,"marketCap":22244876240},{"date":"2023-12-15","current":-45.898269,"twenty":-23.736221,"median":-19.734764,"eighty":-13.845853,"marketCap":23401921026},{"date":"2023-12-22","current":-44.583937,"twenty":-23.77581,"median":-19.757416,"eighty":-14.120072,"marketCap":22731788796},{"date":"2023-12-29","current":-48.170046,"twenty":-23.822082,"median":-19.783129,"eighty":-14.367772,"marketCap":24560220743},{"date":"2024-01-05","current":-47.333205,"twenty":-23.844655,"median":-19.807815,"eighty":-14.75304,"marketCap":24133544791},{"date":"2024-01-12","current":-48.014985,"twenty":-23.882639,"median":-19.870885,"eighty":-15.036722,"marketCap":24481160199},{"date":"2024-01-19","current":-45.76782,"twenty":-23.918488,"median":-19.911073,"eighty":-15.412046,"marketCap":23335409775},{"date":"2024-01-26","current":-45.270638,"twenty":-23.968475,"median":-19.927445,"eighty":-15.562675,"marketCap":23081914063},{"date":"2024-02-02","current":-43.05301,"twenty":-24.015835,"median":-20.029967,"eighty":-15.63923,"marketCap":21951222790},{"date":"2024-02-09","current":-41.718987,"twenty":-24.082663,"median":-20.094473,"eighty":-15.694339,"marketCap":21271051126},{"date":"2024-02-16","current":-42.17723,"twenty":-24.120014,"median":-20.170777,"eighty":-15.846091,"marketCap":18568188261},{"date":"2024-02-23","current":-46.577188,"twenty":-24.194328,"median":-20.189771,"eighty":-15.937306,"marketCap":20505234558},{"date":"2024-03-01","current":-43.224295,"twenty":-24.301666,"median":-20.286198,"eighty":-15.983999,"marketCap":19029149864},{"date":"2024-03-08","current":-42.872412,"twenty":-24.350603,"median":-20.350943,"eighty":-16.020647,"marketCap":18874236538},{"date":"2024-03-15","current":-42.491922,"twenty":-24.391814,"median":-20.419426,"eighty":-16.112677,"marketCap":18706728634},{"date":"2024-03-22","current":-41.945503,"twenty":-24.462472,"median":-20.479555,"eighty":-16.18206,"marketCap":18466172169},{"date":"2024-03-28","current":-44.168369,"twenty":-24.548784,"median":-20.564365,"eighty":-16.286147,"marketCap":19444770981},{"date":"2024-04-05","current":-43.510078,"twenty":-24.597426,"median":-20.604507,"eighty":-16.33047,"marketCap":19154963956},{"date":"2024-04-12","current":-43.685291,"twenty":-24.645741,"median":-20.676023,"eighty":-16.376548,"marketCap":19232099736},{"date":"2024-04-19","current":-41.694765,"twenty":-24.679785,"median":-20.745617,"eighty":-16.408211,"marketCap":18355786690},{"date":"2024-04-26","current":-41.278277,"twenty":-24.735113,"median":-20.78686,"eighty":-16.519437,"marketCap":18172431147},{"date":"2024-05-03","current":-57.236943,"twenty":-24.779503,"median":-20.815068,"eighty":-16.569639,"marketCap":19007015000},{"date":"2024-05-10","current":-57.65867,"twenty":-24.844525,"median":-20.851349,"eighty":-16.622402,"marketCap":19147060435},{"date":"2024-05-17","current":-57.601533,"twenty":-25.00667,"median":-20.904024,"eighty":-16.70221,"marketCap":19128086669},{"date":"2024-05-24","current":-56.900655,"twenty":-25.149654,"median":-21.004296,"eighty":-16.822555,"marketCap":18895341797},{"date":"2024-05-31","current":-57.148248,"twenty":-25.255723,"median":-21.073915,"eighty":-16.859221,"marketCap":18977561453},{"date":"2024-06-07","current":-56.870182,"twenty":-25.347123,"median":-21.129583,"eighty":-16.887735,"marketCap":18885222455},{"date":"2024-06-14","current":-60.964987,"twenty":-25.505018,"median":-21.183931,"eighty":-16.909501,"marketCap":20245009068},{"date":"2024-06-21","current":-59.95557,"twenty":-25.578297,"median":-21.284168,"eighty":-16.967684,"marketCap":19909805857},{"date":"2024-06-28","current":-94.085297,"twenty":-25.649087,"median":-21.320549,"eighty":-17.024098,"marketCap":31243469166},{"date":"2024-07-05","current":-94.72523,"twenty":-25.795936,"median":-21.367736,"eighty":-17.088989,"marketCap":31455975353},{"date":"2024-07-12","current":-99.425685,"twenty":-25.890872,"median":-21.442178,"eighty":-17.124493,"marketCap":33016883893},{"date":"2024-07-15","current":-99.23142,"twenty":-25.946436,"median":-21.470821,"eighty":-17.14142,"marketCap":32952373086},{"date":"2024-08-02","current":-472.76963,"twenty":-25.989694,"median":-21.536305,"eighty":-17.301459,"marketCap":34484289596},{"date":"2024-08-09","current":-476.025741,"twenty":-26.180928,"median":-21.570371,"eighty":-17.375217,"marketCap":34721793545},{"date":"2024-08-16","current":-462.367678,"twenty":-26.389498,"median":-21.613116,"eighty":-17.496759,"marketCap":33725560765},{"date":"2024-08-23","current":-488.117351,"twenty":-26.466864,"median":-21.698382,"eighty":-17.564916,"marketCap":35603767670},{"date":"2024-08-30","current":-505.154728,"twenty":-26.510825,"median":-21.747103,"eighty":-17.642126,"marketCap":36846491036},{"date":"2024-09-06","current":-442.619808,"twenty":-26.609315,"median":-21.79413,"eighty":-17.671918,"marketCap":32285131409},{"date":"2024-09-13","current":-460.66042,"twenty":-26.727788,"median":-21.856374,"eighty":-17.778133,"marketCap":33601031667},{"date":"2024-09-20","current":-486.357291,"twenty":-26.831444,"median":-21.898079,"eighty":-17.810675,"marketCap":35475387157},{"date":"2024-09-27","current":-483.259586,"twenty":-26.949033,"median":-21.95161,"eighty":-17.875623,"marketCap":35249437454},{"date":"2024-10-04","current":-474.388885,"twenty":-27.127664,"median":-22.02445,"eighty":-17.90729,"marketCap":34602399668},{"date":"2024-10-11","current":-490.387828,"twenty":-27.277785,"median":-22.134148,"eighty":-17.977566,"marketCap":35769378532},{"date":"2024-10-18","current":-522.29771,"twenty":-27.328719,"median":-22.171375,"eighty":-18.036248,"marketCap":38096917232},{"date":"2024-10-25","current":-516.911927,"twenty":-27.387695,"median":-22.181975,"eighty":-18.064397,"marketCap":37704072862},{"date":"2024-10-31","current":-495.439199,"twenty":-27.690618,"median":-22.217711,"eighty":-18.076673,"marketCap":36137830604},{"date":"2024-11-08","current":-105.672553,"twenty":-27.928925,"median":-22.249016,"eighty":-18.149076,"marketCap":35111185225},{"date":"2024-11-15","current":-100.117582,"twenty":-28.278735,"median":-22.281263,"eighty":-18.197623,"marketCap":33265468303},{"date":"2024-11-22","current":-95.804813,"twenty":-38.629396,"median":-22.303077,"eighty":-18.234444,"marketCap":31832490315},{"date":"2024-11-29","current":-98.238752,"twenty":-39.851355,"median":-22.331849,"eighty":-18.261794,"marketCap":32641200665},{"date":"2024-12-06","current":-97.749635,"twenty":-40.312601,"median":-22.375689,"eighty":-18.326476,"marketCap":32478684709},{"date":"2024-12-13","current":-95.207003,"twenty":-41.145142,"median":-22.431629,"eighty":-18.400406,"marketCap":31633859703},{"date":"2024-12-20","current":-92.726481,"twenty":-41.360035,"median":-22.487731,"eighty":-18.448586,"marketCap":30809671643},{"date":"2024-12-27","current":-94.135604,"twenty":-41.606752,"median":-22.522416,"eighty":-18.498894,"marketCap":31277872372},{"date":"2025-01-03","current":-90.688494,"twenty":-41.723334,"median":-22.544716,"eighty":-18.572168,"marketCap":30132521829},{"date":"2025-01-10","current":-93.378637,"twenty":-41.861427,"median":-22.57894,"eighty":-18.59486,"marketCap":31026359584},{"date":"2025-01-17","current":-96.720937,"twenty":-41.948936,"median":-22.622206,"eighty":-18.683926,"marketCap":32136885279},{"date":"2025-01-24","current":-106.961338,"twenty":-42.059925,"median":-22.654972,"eighty":-18.702056,"marketCap":35539401870},{"date":"2025-01-31","current":-107.590202,"twenty":-42.181976,"median":-22.737733,"eighty":-18.735467,"marketCap":35748350955},{"date":"2025-02-07","current":-108.013327,"twenty":-42.403094,"median":-22.787084,"eighty":-18.784348,"marketCap":35888940155},{"date":"2025-02-14","current":-123.282556,"twenty":-42.573057,"median":-22.844236,"eighty":-18.809989,"marketCap":34291906052},{"date":"2025-02-21","current":-116.818006,"twenty":-42.724221,"median":-22.855438,"eighty":-18.833903,"marketCap":32493746156},{"date":"2025-02-28","current":-110.348802,"twenty":-42.838654,"median":-22.880662,"eighty":-18.882582,"marketCap":30694291687},{"date":"2025-03-07","current":-115.482278,"twenty":-43.165626,"median":-22.931767,"eighty":-18.960996,"marketCap":32122204118},{"date":"2025-03-14","current":-112.51296,"twenty":-43.507909,"median":-22.979462,"eighty":-19.021306,"marketCap":31296267463},{"date":"2025-03-21","current":-118.002476,"twenty":-43.935758,"median":-22.995874,"eighty":-19.120529,"marketCap":32823214618},{"date":"2025-03-28","current":-126.135522,"twenty":-44.245026,"median":-23.069068,"eighty":-19.189745,"marketCap":35085478419},{"date":"2025-04-04","current":-122.011986,"twenty":-44.566215,"median":-23.109369,"eighty":-19.259083,"marketCap":33938488016},{"date":"2025-04-11","current":-105.313062,"twenty":-45.269161,"median":-23.143624,"eighty":-19.312162,"marketCap":29293565259},{"date":"2025-04-17","current":-107.277093,"twenty":-45.525616,"median":-23.178773,"eighty":-19.357271,"marketCap":29839874458},{"date":"2025-04-25","current":-112.913213,"twenty":-46.047424,"median":-23.269727,"eighty":-19.404321,"marketCap":31407600617},{"date":"2025-05-02","current":-123.343965,"twenty":-46.659302,"median":-23.299825,"eighty":-19.466109,"marketCap":33265990706},{"date":"2025-05-09","current":-124.900691,"twenty":-47.223923,"median":-23.401211,"eighty":-19.500963,"marketCap":33685841331}],"updateTime":1746931884886}}}